Flavonoid Fraction of Citrus Reticulata Juice Reduces Proliferation and Migration of Anaplastic Thyroid Carcinoma Cells

REFERENCES

• Meiyanto E, Hermawan A, and Anindyajati, A: Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev 13, 427–436, 2012.
   PubMed Web of Science ®Google Scholar
• Benavente-Garcia O, and Castillo J: Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56, 6185–6205, 2008.
   PubMed Web of Science ®Google Scholar
• Gattuso G, Barreca D, Gargiulli C, Leuzzi U, and Caristi C: Flavonoid composition of Citrus juices. Molecules 12, 1641–1673, 2007.
   PubMed Web of Science ®Google Scholar
• Chun OK, Chung SJ, and Song WO: Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 137, 1244–1252, 2007.
   PubMed Web of Science ®Google Scholar
• Grosso G, Galvano F, Mistretta A, Marventano S, Nolfo F, et al.: Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxid Med Cell Longev 157240, 2013. doi:10.1155/2013/157240
   Web of Science ®Google Scholar
• Manthey JA, Grohmann K, and Guthrie N: Biological properties of Citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 8, 135–153, 2001.
   PubMed Web of Science ®Google Scholar
• Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, et al.: The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 22, 1252–1259, 2013.
   PubMed Web of Science ®Google Scholar
• Tuttle RM: Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation? Endocrine 46, 363–364, 2014.
   PubMed Web of Science ®Google Scholar
• Denaro N, Lo Nigro C, Russi EG, and Merlano MC: The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer. Onco Targets Ther 9, 1231–1241, 2013.
   PubMedGoogle Scholar
• Schlumberger M, Lacroix L, Russo D, Filetti S, and Bidart JM: Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nat Clin Pract Endocrinol Metab 3, 260–269, 2007.
   PubMedGoogle Scholar
• Elisei R: Anaplastic thyroid cancer therapy: dream or reality? Endocrine 42, 468–470, 2012.
   PubMed Web of Science ®Google Scholar
• Pilli T, Prasad KV, Jayarama S, Pacini F, and Prabhakar BS: Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer. Thyroid 19, 1333–1342, 2009.
   PubMed Web of Science ®Google Scholar
• D'Agostino M, Voce P, Celano M, Sponziello M, Moretti S, et al.: Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells. Thyroid 22, 138–144, 2012.
   PubMed Web of Science ®Google Scholar
• Navarra M, Celano M, Maiuolo J, Schenone S, Botta M, et al.: Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cells. BMC Cancer 10, 602, 2010.
   PubMed Web of Science ®Google Scholar
• Bulotta S, Corradino R, Celano M, Maiuolo J, D'Agostino M, et al.: Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells. J Mol Endocrinol 51, 181–189, 2013.
   PubMed Web of Science ®Google Scholar
• Maggisano V, Puppin C, Celano M, D'Agostino M, Sponziello M, et al.: Cooperation of histone deacetylase inhibitors SAHA and valproic acid in promoting sodium/iodide symporter expression and function in rat Leydig testicular carcinoma cells. Endocrine 45, 148–152, 2014.
   PubMed Web of Science ®Google Scholar
• Bulotta S, Ierardi MV, Maiuolo J, Cattaneo MG, Cerullo A, et al.: Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells. Biochem Biophys Res Commun 386, 744–749, 2009.
   PubMed Web of Science ®Google Scholar
• Baldini E, Toller M, Graziano F M, Russo FP, Pepe M, et al.: Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. Thyroid 14, 881–888, 2004.
   PubMed Web of Science ®Google Scholar
• Schweppe RE: Thyroid cancer cell lines: critical models to study thyroid cancer biology and new therapeutic targets. Front Endocrinol (Lausanne) 3, 81, 2012.
   PubMedGoogle Scholar
• Perri F, Di Lorenzo G, Della Vittoria Scarpati G, and Buonerba C: Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol 2(3), 150–157, 2011.
   PubMedGoogle Scholar
• Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, et al.: Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells. Mol Cell Endocrinol 369, 130–139, 2013.
   PubMed Web of Science ®Google Scholar
• Yu XM, Phan T, Patel PN, Jaskula-Sztul R, and Chen H:. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer 119, 774–781, 2013.
   PubMed Web of Science ®Google Scholar
• Sak K: Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev 8(16), 122–146, 2014.
   PubMedGoogle Scholar
• Ravishankar D, Rajora AK, Greco F, and Osborn HM: Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol, 45, 2821–2831, 2013.
   PubMed Web of Science ®Google Scholar
• Ramos S: Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52, 507–526, 2008.
   PubMed Web of Science ®Google Scholar
• Delle Monache S, Sanità P, Trapasso E, Ursino MR, Dugo P, et al.: Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juice. PLoS One 8, e61484, 2013.
   PubMed Web of Science ®Google Scholar
• Navarra M, Ursino MR, Ferlazzo N, Russo M, Schumacher U, et al.: Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models. Fitoterapia 95, 83–92, 2014.
   PubMed Web of Science ®Google Scholar
• Visalli G, Ferlazzo N, Cirmi S, Campiglia P, Gangemi S, et al: Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells. Anticancer Agents Med Chem 14, 1402–1413, 2014.
   PubMed Web of Science ®Google Scholar
• Risitano R, Currò M, Cirmi S, Ferlazzo N, Campiglia P, et al: Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes. PLoS One 9(9), e107431, 2014.
   PubMed Web of Science ®Google Scholar
• Impellizzeri D, Bruschetta G, Di Paola R, Ahmad A, Campolo M, et al: The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin Nutr. doi:10.1016/j.clnu.2014.11.012, in press.
   Web of Science ®Google Scholar
• Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, et al.: Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochem Pharmacol 82, 1100–1109, 2011.
   PubMed Web of Science ®Google Scholar
• Morley KL, Ferguson PJ, and Koropatnick J: Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 251, 168–178, 2007.
   PubMed Web of Science ®Google Scholar
• Liu RH: Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134, 3479S–3485S, 2004.
   PubMed Web of Science ®Google Scholar
• Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768–780, 2003.
   PubMed Web of Science ®Google Scholar
• Bulotta S, Celano M, Lepore SM, Montalcini T, Pujia A, et al.: Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases. J Trans Med 516981 2012. doi: 10.1155/2012/516981.
   Web of Science ®Google Scholar
• Tanaka T, Tanaka T, Tanaka M, and Kuno T: Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin. J Biomed Biotechnol 516981, 2012.
   PubMedGoogle Scholar
• Yeh MW, Rougier JP, Park JW, Duh QY, Wong M, et al.: Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. Endocr Relat Cancer 13, 1173–1183, 2006.
   PubMed Web of Science ®Google Scholar
• Liang H, Zhong Y, Luo Z, Huang Y, Lin H, et al.: Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. Int J Biol Markers 25, 38–45, 2010.
   PubMed Web of Science ®Google Scholar
• Erlund I, Silaste ML, Alfthan G, Rantala M, Kesäniemi YA, et al.: Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr 56, 891–898, 2002.
   PubMed Web of Science ®Google Scholar
• Gonçalves CF, Santos MC, Ginabreda MG, Fortunato RS, Carvalho DP, et al.: Flavonoid rutin increases thyroid iodide uptake in rats. PLoS One 8(9), e73908, 2013.
   PubMed Web of Science ®Google Scholar
• Yu XM, Phan T, Patel PN, Jaskula-Sztul R, and Chen H: Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer 119, 774–781, 2013.
   PubMed Web of Science ®Google Scholar
• Somjen D, Grafi-Cohen M, Katzburg S, Weisinger G, Izkhakov E, et al.: Anti-thyroid cancer properties of a novel isoflavone derivative, 7-(O)-carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine in vitro and in vivo. J Steroid Biochem Mol Biol 126(3–5), 95–103, 2011.
   PubMed Web of Science ®Google Scholar